Working with Iryna Avrutova: How a Fractional CRO Engagement Actually Runs

Iryna Avrutova is a Fractional CRO and sales consultant working with B2B SaaS founders, typically between $1M and $20M ARR, who need senior revenue leadership without committing to a full-time hire. Her work is operational, not advisory-only. Inside a fractional CRO engagement, she owns the pipeline, runs the sales team, sits in deal reviews, coaches AEs through enterprise opportunities, and installs the operating infrastructure — forecasting cadence, qualification framework, pricing discipline, hiring scorecards — that the company will keep using after she leaves.

There are several things she does not do, and the distinction matters. She does not act as employee-of-record for the sales team — AEs and BDRs remain employed by the company, with HR, payroll, and benefits handled internally. She does not attend daily standups; cadence is weekly pipeline reviews, monthly business reviews, and quarterly board updates. She does not take recruiting commissions on hires placed during the engagement, which keeps the hiring recommendation honest. And she does not accept the role of fractional-CRO-on-paper-only — a title used for board optics without operational authority over revenue decisions. That arrangement fails on both sides and she declines it before it starts.

The shape of the work, in practice: one company at a time, 10–15 hours per week embedded, a fixed engagement window that ends with a documented handoff. Read more on Iryna's background and approach, or jump to the contact form if you'd rather start with a conversation.

The first call is 45 minutes and it is diagnostic, not a sales pitch. I want to understand whether the engagement is the right fit before either of us spends more time on it.

I ask about three things: current ARR and the trailing growth rate, what the sales team looks like today (headcount, ramp status, who closes what), and what specifically triggered you to look for help now. The third question is the most informative — "we want to grow faster" tells me nothing, but "the founder is on every deal above $80K and the board flagged it" tells me almost everything.

I don't ask about your stack, your last fundraise valuation, or your competitors. Those are easy to research and they're not what determines whether I can help.

The red flags I listen for: a founder who already knows what I should do and just wants validation; revenue numbers that don't reconcile with team size; a description of the problem that blames the AEs rather than the system. None of these are deal-breakers — they're conversations to have honestly before any contract gets drafted. If we both leave the call clear on whether this is a fit, the call was worth doing.

Four formats, chosen by what the company actually needs. The wrong format is worse than no engagement.

Advisory. Board observer plus a monthly working session. ~4 hours per month. Deliverables: written recommendations after each session, async availability for specific decisions between sessions, optional attendance at one board meeting per quarter. Exit: open-ended, typically 6–12 months. Right when the founder still owns the commercial process but wants senior sparring on big decisions — pricing changes, first VP Sales hire, enterprise segment expansion. For deeper detail, see sales advisory for SaaS founders.

Fractional CRO. Embedded leadership, 10–15 hours per week, 6–12 month minimum engagement. Deliverables: pipeline ownership, team management, forecasting, hiring decisions, and the operating system the company keeps. Exit: documented handoff to a full-time successor or, more often, to a senior internal hire promoted into the role. Right when the selling motion exists but is founder-dependent, the team has 3+ AEs, and the company needs a CRO but is too early to fund a full-time one. For the underlying definition see what is a fractional CRO; for the week-by-week shape of the first quarter, what a fractional CRO does in the first 90 days; and for the cost comparison against the full-time alternative, fractional CRO vs full-time CRO.

Transformation Project. Fixed 12-week scope. Deliverables: pre-engagement audit, system design, installation of qualification framework, pricing discipline, pipeline mechanics, and AE enablement. Exit: defined end-date with a final report and a 30-day post-engagement check-in. Right when the team isn't ready for a fractional CRO yet — qualification is absent, pipeline is full of founder relationships, AEs have never operated independently. See sales transformation consulting engagement for the phase-by-phase breakdown.

Workshop. Two consecutive days, on-site or remote. Deliverables: a pricing memo, GTM alignment document, or sales playbook draft — whichever the company needs. Exit: end of day two. Right when there's a specific decision to make (pricing reset, ICP redefinition, GTM realignment) and the company wants a structured forcing function rather than a long engagement. See the 2-day GTM workshop framework for the agenda shape.

If you're unsure which format applies, the first call will sort it. The honest answer is sometimes "none of the above, not right now" — see the section below.

A representative engagement, anonymized: B2B SaaS company in vertical workflow software, around $4M ARR, three AEs and one SDR, growth rate decelerating from 90% YoY to 35% over four quarters. The founder was on every deal above $60K ACV — about 60% of revenue passed through them personally. The board had flagged founder-dependency twice. I came in as Fractional CRO on a 9-month engagement.

In the first 60 days, I ran the pre-engagement audit, mapped the existing pipeline against a coverage benchmark for their ACV band, and identified that two of the three AEs were carrying realistic quota loads while one was being asked to do something the comp plan didn't actually reward. I rewrote the qualification rubric, installed weekly pipeline reviews with the founder as observer only, and introduced a discount-authority matrix that took 80% of pricing decisions off the founder's desk.

At month six, the founder was involved in 4 deals — all above $250K ACV, all at executive-relationship stage rather than commercial process. Win rate on deals above $60K had moved from 22% to 31%. Growth re-accelerated to 52% YoY at the next quarter-end. The handoff was to a newly-promoted Head of Sales, internal, who I had spent the last two months specifically preparing for the role.

The engagement ended on the planned date. I haven't taken a board seat there or extended.

Some engagements I decline, and the honesty here protects both sides. A bad-fit engagement burns 6–12 months and damages the company more than no engagement would.

I say no when the company is pre-PMF. If you're still discovering your ICP, iterating on the core value proposition, or losing deals because the product doesn't yet solve the problem — you need product work, not revenue leadership. A fractional CRO accelerates a working motion; we cannot manufacture one from nothing. The founder-led sales transition playbook covers the specific ARR signals that mark readiness.

I say no below roughly $500K ARR with no clear product-market fit signal. The data sample is too small, the deals are too few to find patterns in, and any process I install will be premature. Founder-led selling is the correct mode at that stage.

I say no when the founder is looking for a yes-person. If our first conversations make it clear that what's wanted is validation of decisions already made — not a senior commercial partner who will sometimes push back — the engagement will fail. I'm not interested in being the third opinion that agrees with the first two.

And I say no to equity-only arrangements with no cash component. Not because equity isn't aligned, but because the implied valuation of my time is usually unrealistic and the structure rarely produces an honest working relationship. A reasonable mix is fine; equity-as-the-whole-package isn't.

If any of these apply, I'll tell you on the first call and recommend what would help instead — often a specific workshop, a referral, or a 90-day reassessment date.

If you've read this far and the fit seems plausible, the next step is a 45-minute first call. Use the contact form — short answers to the diagnostic questions are more useful than a long message. I respond personally within two business days.

For more context before reaching out: my background and approach covers the work history and method, the fractional CRO service page covers scope and cost detail, and 12 questions to ask before hiring a fractional CRO is the diagnostic I'd suggest you run on yourself first — including questions to ask me on the first call.

No nurture sequences. If we agree it's a fit, we move quickly to a scoped proposal. If not, that's also a fine outcome — better than the alternative.